-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Accendra Health, Raises Price Target to $6

Benzinga·05/12/2026 11:32:28
Listen to the news
Baird analyst Eric Coldwell maintains Accendra Health (NYSE:ACH) with a Outperform and raises the price target from $5 to $6.